Evidence map›Paper›PMID 39026469›Full record

ArticleACS chemical biology2024

Light-Inducible Activation of TrkA for Probing Chronic Pain in Mice.

Aofei Liu, Manuel A Mohr, Jen M Hope, Jennifer Wang, Xiaoke Chen, Bianxiao Cui

Abstract read
In one paragraph

Article in ACS chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Development of PROTACs for targeted degradation of oncogenic TRK fusions.bioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aofei LiuDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.ORCID 0000-0003-3212-9952
Manuel A MohrDepartment of Biology, Stanford University, Stanford, California 94305, United States.
Jen M HopeDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.ORCID 0000-0002-9601-4778
Jennifer WangDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.
Xiaoke ChenDepartment of Biology, Stanford University, Stanford, California 94305, United States.
Bianxiao CuiDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.ORCID 0000-0002-8044-5629

Funding

ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI CHANG, EUGENE B · 1990 to 2025
$29.8M
Nanoscale probes for sensing molecular functions in live cellsR35GM141598 · NIGMS · STANFORD UNIVERSITY · PI CUI, BIANXIAO · 2021 to 2025
$3.4M
Thalamic Circuits Underlying Opioid SeekingR01DA045664 · NIDA · STANFORD UNIVERSITY · PI CHEN, XIAOKE · 2018 to 2022
$2.3M
Label-free Optical Recording of Neuroelectric ActivitiesR01NS121934 · NINDS · STANFORD UNIVERSITY · PI CUI, BIANXIAO, MUELLER, HOLGER · 2021 to 2025
$2.2M
Thalamic Circuits for Prosocial Behaviors in MiceR01MH116904 · NIMH · STANFORD UNIVERSITY · PI CHEN, XIAOKE · 2019 to 2022
$1.8M
Rapid brain-wide optogenetic screening with a noninvasive, dynamically programmable in vivo light sourceRF1NS126076 · NINDS · STANFORD UNIVERSITY · PI BUTTS-PAULY, KIM, CHEN, XIAOKE · 2022 to 2022
$1.8M
NIDA NIH HHS R01 DA045664NIDDK NIH HHS P30 DK042086NIGMS NIH HHS R35 GM141598NIMH NIH HHS R01 MH116904NINDS NIH HHS R01 NS121934NINDS NIH HHS RF1 NS126076
6 · The paper itself

Abstract

Chronic pain is a prevalent problem that plagues modern society, and better understanding its mechanisms is critical for developing effective therapeutics. Nerve growth factor (NGF) and its primary receptor, Tropomyosin receptor kinase A (TrkA), are known to be potent mediators of chronic pain, but there is a lack of established methods for precisely perturbing the NGF/TrkA signaling pathway in the study of pain and nociception. Optobiological tools that leverage light-induced protein-protein interactions allow for precise spatial and temporal control of receptor signaling. Previously, our lab reported a blue light-activated version of TrkA generated using light-induced dimerization of the intracellular TrkA domain, opto-iTrkA. In this work, we show that opto-iTrkA activation is able to activate endogenous ERK and Akt signaling pathways and causes the retrograde transduction of phospho-ERK signals in dorsal root ganglion (DRG) neurons. Opto-iTrkA activation also sensitizes the transient receptor potential vanilloid 1 (TRPV1) channel in cellular models, further corroborating the physiological relevance of the optobiological stimulus. Finally, we show that opto-iTrkA enables light-inducible potentiation of mechanical sensitization in mice. Light illumination enables nontraumatic and reversible (<2 days) sensitization of mechanical pain in mice transduced with opto-iTrkA, which provides a platform for dissecting TrkA pathways for nociception

Indexed as

Chronic PainGanglia, SpinalLightReceptor, trkAAnimalsHumansMaleMiceMice, Inbred C57BLNerve Growth FactorNeuronsSignal TransductionTRPV Cation ChannelsNerve Growth FactorNtrk1 protein, mouseReceptor, trkATRPV Cation Channels

Identifiers

PMID39026469
PMCPMC11756861

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.